Serveur d'exploration Chloroquine - Exploration (Accueil)

Index « Teeft.i » - entrée « Antirheumatic »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antiretroviral treatment < Antirheumatic < Antirheumatic activity  Facettes :

List of bibliographic references indexed by Antirheumatic

Number of relevant bibliographic references: 39.
[0-20] [0 - 20][0 - 39][20-38][20-40]
Ident.Authors (with country if any)Title
001135 (2013) Prabha Ranganathan [États-Unis]Herpes zoster infection risk in patients with rheumatoid arthritis on tumour necrosis factor inhibitors
001441 (2012) Larry W. Moreland [États-Unis] ; James R. O'Dell ; Harold E. Paulus ; Jeffrey R. Curtis ; Joan M. Bathon [États-Unis] ; E. William St. Clair [États-Unis] ; S. Louis Bridges Jr. ; Jie Zhang ; Theresa Mcvie ; George Howard ; Désirée Van Der Heijde [Pays-Bas] ; Stacey S. CofieldA randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial
001481 (2011) W G Dixon [Royaume-Uni, Canada] ; A. Kezouh [Canada] ; S. Bernatsky [Canada] ; S. Suissa [Canada]The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case–control study
001B71 (2007) Lester E. Mertz [États-Unis] ; Janis E. Blair [États-Unis]Coccidioidomycosis in Rheumatology Patients
001B88 (2007) Gerd R. Burmester [Allemagne] ; Xavier Mariette [France] ; Carlomaurizio Montecucco [Italie] ; Indalecio Monteagudo-Sáez [Espagne] ; Michel Malaise [Belgique] ; Athanasios G. Tzioufas [Grèce] ; Johannes W J. Bijlsma [Pays-Bas] ; Kristina Unnebrink [Allemagne] ; Sonja Kary [Allemagne] ; Hartmut Kupper [Allemagne]Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial
001D58 (2006) X. Le Loët [France] ; J M Berthelot [France] ; A. Cantagrel [France] ; B. Combe [France] ; M. De Bandt [France] ; B. Fautrel [France] ; R M Flipo [France] ; F. Lioté [France] ; J F Maillefert [France] ; O. Meyer ; A. Saraux [France] ; D. Wendling [France] ; F. Guillemin [France]Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology
002240 (2002) E N Harris [États-Unis]Antirheumatic drugs in pregnancy
002283 (2001) James R. O'DellCOMBINATIONS OF CONVENTIONAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS
002458 (2000) Lydia A. Percy ; Meika A. FangGEROPHARMACOLOGY FOR THE RHEUMATOLOGIST
002470 (2000) Eric L. MattesonCurrent Treatment Strategies for Rheumatoid Arthritis
002597 (1999) Dimitrios Vassilopoulos ; Charles Camisa ; Robert M. Strauss [Géorgie (pays)]SELECTED DRUG COMPLICATIONS AND TREATMENT CONFLICTS IN THE PRESENCE OF COEXISTENT DISEASES
002661 (1999) Index
002738 (1998) Daniel Libby [États-Unis] ; Dorothy A. White [États-Unis]PULMONARY TOXICITY OF DRUGS USED TO TREAT SYSTEMIC AUTOIMMUNE DISEASES
002857 (1997) Jan BondesonThe mechanisms of action of disease-modifying antirheumatic drugs: A review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines
002859 (1997) Lawrence H. Brent [États-Unis] ; David A. Beckman [États-Unis] ; Robert L. Brent [États-Unis]The effects of antirheumatic drugs on reproductive function
002861 (1997) Rita Jain ; Peter E. LipskyTREATMENT OF RHEUMATOID ARTHRITIS
002869 (1997) Maarten Boers [Pays-Bas] ; Arco C. Verhoeven [Pays-Bas] ; Harry M. Markusse [Pays-Bas] ; Mart Afj Van De Laar [Pays-Bas] ; Rene Westhovens [Belgique] ; J Christiaan Van Denderen [Pays-Bas] ; Derkjen Van Zeben ; Ben Ac Dijkmans [Pays-Bas] ; Andre J. Peeters ; Piet Jacobs ; Hans R. Van Den Brink [Pays-Bas] ; Hubert Ja Schouten [Pays-Bas] ; Dsire Mfm Van Der Heijde [Pays-Bas] ; Annelies Boonen [Pays-Bas] ; Sjef Van Der Linden [Belgique]Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
002925 (1997) Jan M. Kriebs ; Karen B. Burgin [États-Unis]PHARMACOLOGIC MANAGEMENT OF COMMON MUSCULOSKELETAL DISORDERS IN WOMEN
002D83 (1993) Ruth V. Waters [États-Unis] ; Donna Webster [États-Unis] ; Anthony C. Allison [États-Unis]Mycophenolic Acid and Some Antioxidants Induce Differentiation of Monocytic Lineage Cells and Augment Production of the IL‐1 Receptor Antagonist
003008 (1990) Math J. Wijnands [Pays-Bas] ; Piet L. Van Riel [Pays-Bas] ; Frank W. Gribnau ; Levinus B. Van De Putt [Pays-Bas]Risk factors of second-line antirheumatic drugs in rheumatoid arthritis
003012 (1990) Robert F. Willkens [États-Unis]Resolve: Methotrexate is the drug of choice after NSAIDs in rheumatoid arthritis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i -k "Antirheumatic" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Teeft.i  \
                -Sk "Antirheumatic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Antirheumatic
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021